|Articles|July 14, 2015
New Release Clinical Conductor CTMS
The new Clinical Conductor contains a myriad of enhancements that foster more precise reporting and analysis.
Advertisement
Bio-Optronics announces its Clinical Conductor CTMS has been updated with enhancements that include:
- Adverse Event (AE/SAE) management enhancements (e.g. wizards for reporting, audit trails for review, document uploads, etc.)
- Billing compliance review functionality additions at the site level, as well as the enterprise level for sponsors, CROs, health systems and other networks
- Invoicing features that allow organizations to set invoicing caps, frequencies and much more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5